Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
Phase of Trial: Phase IV
Latest Information Update: 24 Dec 2016
Price : $35 *
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Opioid analgesics
- Indications Pain
- Focus Therapeutic Use
- 28 Oct 2016 Status changed from active, no longer recruiting to discontinued.
- 25 Feb 2016 Planned End Date changed from 1 Oct 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
- 10 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.